SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-22-045540
Filing Date
2022-12-14
Accepted
2022-12-14 16:30:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10045401_sc13da.htm SC 13D/A 49312
  Complete submission text file 0001140361-22-045540.txt   50879
Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42217 | Film No.: 221462497
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Filed by) CIK: 0001448698 (see all company filings)

Type: SC 13D/A